BOSTON SCIENTIFIC CORP is 37.3x more valuable than Pulse Biosciences, Inc. by market capitalization ($70.11 B vs $1.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PLSE | BSX |
|---|---|---|
| Market cap | $1.88 B | $70.11 B |
| US-listed rank | #2150 | #243 |
| Revenue (latest FY) | $350.00K | $20.07B |
| Net income (latest FY) | -$72.78M | - |
| Net margin | -20794.6% | - |
| SEC filings | 616 | 1,009 |
BOSTON SCIENTIFIC CORP is 37.3x more valuable than Pulse Biosciences, Inc. by market capitalization ($70.11 B vs $1.88 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: Pulse Biosciences, Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.